Anja Möricke

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi et al. · Blood · 2010 · 786 citations · Full text

Medicine, Hematology, Oncology +11

The MLL recombinome of acute leukemias in 2017

Claus Meyer, Thomas Burmeister, Daniela Gröger et al. · Leukemia · 2017 · 686 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Anja Möricke, Alfred Reiter, Martin Zimmermann et al. · Blood · 2008 · 610 citations · Full text

Medicine, Oncology, Pediatrics +14

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

Anja Möricke, M Zimmermann, Alfred Reiter et al. · Leukemia · 2009 · 521 citations

Medicine, Hematology, Oncology +9

The MLL recombinome of acute leukemias in 2013

Claus Meyer, Jörg Hofmann, Thomas Burmeister et al. · Leukemia · 2013 · 507 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17